COVID-19 Pneumonia
📧 Sign up to get email alerts when something new happens for COVID-19 Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Results: ARrest RESpiraTory Failure From PNEUMONIA [Phase 3]
Phase 3 trial results for ARrest RESpiraTory Failure From PNEUMONIA were terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster Dose
This clinical trial update summarizes results from a completed study on breakthrough COVID-19 infections in fully vaccinated people and in t…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: CX-4945 in Viral Community Acquired Pneumonia [Phase 2]
A Phase 2 trial of CX-4945 for viral community-acquired pneumonia, including COVID-19 pneumonia and influenza with pneumonia, was terminated…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Study of Auxora in Patients With Critical COVID-19 Pneumonia [Phase 2]
Phase 2 trial of Auxora in patients with critical COVID-19 pneumonia was terminated. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: Pulmonary Diffusion of Antibiotics in Patients Admitted for ARDS Following SARS-CoV-2 Pneumonia [NA]
A completed clinical trial update studying how antibiotics distribute within the lungs of patients with acute respiratory distress syndrome …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: High Velocity Nasal Insufflation Versus Continuous Positive Airway Pressure in COVID 19 Pneumonic Patients [NA]
A clinical trial comparing high velocity nasal insufflation to standard CPAP in patients with COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: ARrest RESpiraTory Failure From PNEUMONIA [Phase 3]
A Phase 3 trial investigating a treatment for pneumonia-related respiratory failure was terminated.
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Tofacitinib for Treatment of Moderate COVID-19 [Phase 2]
Phase 2 trial evaluating tofacitinib for moderate COVID-19 pneumonia has been terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT [EARLY_Phase 1]
An early-phase study update on detecting integrin αvβ6 with PET/CT in patients with idiopathic pulmonary fibrosis, primary sclerosing cholan…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Tele-rehabilitation Program After Hospitalization for COVID-19 [NA]
A completed clinical trial evaluated a tele-rehabilitation program after hospitalization for COVID-19 pneumonia. The update provides the tri…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP) [NA]
Clinical trial update on the efficacy and safety of an antimicrobial stewardship intervention in hospitalized COVID-19 patients (COVASP).
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 Disease [NA]
This clinical trial update reports the completion of a study evaluating the efficacy and safety of the Dr Biolyse electrical signal therapy …
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: CPAP Therapy Through a Helmet or a Full Face Mask in Patients With Acute Hypoxemic Respiratory Failure: Cross-over Study [NA]
A cross-over trial comparing helmet CPAP to full-face mask CPAP in patients with acute hypoxemic respiratory failure; the study status is co…
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells [Phase 2]
Phase 2 clinical trial evaluating allogeneic mesenchymal stem cells for treatment of severe COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19 [Phase 2, Phase 3]
A Phase 2/3 clinical trial of GST-HG171/Ritonavir versus placebo in patients with COVID-19 pneumonia has completed recruitment and status is…
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: NAC for Attenuation of COVID-19 Symptomatology [Phase 2]
A Phase 2 clinical trial is updating on N-acetylcysteine (NAC) for attenuation of COVID-19 symptomatology, with various COVID-19-related res…
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia [Phase 1, Phase 2]
Clinical trial update on safety, tolerability, and efficacy of Uproleselan (GMI-1271) in COVID-19 pneumonia, terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Bevacizumab in Patients With Severe Covid-19 [Phase 3]
Phase 3 clinical trial evaluating bevacizumab for patients with severe COVID-19 pneumonia; status is currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia [Phase 2, Phase 3]
A randomized, controlled study of IFX-1 (vilobelimab) in patients with severe COVID-19 pneumonia completed Phase 2/3 with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia [Phase 2]
Phase 2 clinical trial assessing inhaled GM-CSF to prevent ARDS in patients with COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 [Phase 2]
Phase 2 open-label trial of dipyridamole in hospitalized COVID-19 patients (terminated; results posted).
-
CLINICAL_TRIALS trial_result · 2023-04-20Clinical Trial Update: Evaluation of the Efficacy and Safety of Nano-S1 [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Nano-S1 for COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) [Phase 2]
A Phase 2 clinical trial update for tocilizumab in COVID-19 pneumonia (TOCIVID-19) with unknown current status.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients [Phase 2, Phase 3]
Phase 2b/3 trial update for NuSepin® in COVID-19 pneumonia is ongoing with unspecified status.
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Usefulness of DORNASE in COVID-19 on HFNO [Phase 4]
Phase 4 clinical trial update evaluating the usefulness of DORNASE in COVID-19 pneumonia on high-flow nasal oxygen; the study has been termi…